Dr. Veena Agarwal has completed her PhD from CDIR Lucknow, and post doc from National Institute of Health, Bethesda, USA. She is a biologist and possesses extensive expertise in the discovery and development of cancer therapeutics and setting up the research facilities. Dr. Agarwal has made significant contributions in the R & D phase of two marketed cancer drugs–Nexavar at Bayer Pharmaceuticals, USA, and Bexarotene at Ligand Pharmaceuticals, USA. She has presented many research seminars at international meetings, published in peer-reviewed scientific journals. She is recipient of international honours.